OmniAb, Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies

By leveraging its proprietary technologies and platforms, the company aims to generate a diverse array of high-quality antibodies for various therapeutic applications, focusing primarily on areas such as oncology, autoimmune diseases, and infectious diseases. OmniAb collaborates with other biotechnology and pharmaceutical companies to enhance drug discovery processes, ultimately seeking to advance innovative treatments that can address unmet medical needs.